- Home
- REBN vs TRIB Comparison
REBN vs TRIB Comparison
Compare REBN & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REBN
- TRIB
- Stock Information
- Founded
- REBN 2015
- TRIB 1992
- Country
- REBN United States
- TRIB Ireland
- Employees
- REBN N/A
- TRIB N/A
- Industry
- REBN Restaurants
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- REBN Consumer Discretionary
- TRIB Health Care
- Exchange
- REBN Nasdaq
- TRIB Nasdaq
- Market Cap
- REBN 13.5M
- TRIB 13.0M
- IPO Year
- REBN 2022
- TRIB N/A
- Fundamental
- Price
- REBN $2.47
- TRIB $0.67
- Analyst Decision
- REBN
- TRIB
- Analyst Count
- REBN 0
- TRIB 0
- Target Price
- REBN N/A
- TRIB N/A
- AVG Volume (30 Days)
- REBN 63.4K
- TRIB 2.4M
- Earning Date
- REBN 08-18-2025
- TRIB 08-13-2025
- Dividend Yield
- REBN N/A
- TRIB N/A
- EPS Growth
- REBN N/A
- TRIB N/A
- EPS
- REBN N/A
- TRIB N/A
- Revenue
- REBN $6,103,732.00
- TRIB $61,555,000.00
- Revenue This Year
- REBN $335.98
- TRIB $13.51
- Revenue Next Year
- REBN N/A
- TRIB $13.14
- P/E Ratio
- REBN N/A
- TRIB N/A
- Revenue Growth
- REBN 3.38
- TRIB 8.31
- 52 Week Low
- REBN $1.03
- TRIB $0.48
- 52 Week High
- REBN $8.30
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- REBN 48.86
- TRIB 48.68
- Support Level
- REBN $2.30
- TRIB $0.60
- Resistance Level
- REBN $3.00
- TRIB $0.87
- Average True Range (ATR)
- REBN 0.17
- TRIB 0.08
- MACD
- REBN 0.03
- TRIB 0.01
- Stochastic Oscillator
- REBN 40.60
- TRIB 33.94
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.